Thanigaivelan Kanagasabai
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 4 | 2023 | 794 | 1.090 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2021 | 9 | 0.840 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 18 | 0.830 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 39 | 0.710 |
Why?
|
| Imidazoles | 1 | 2019 | 124 | 0.690 |
Why?
|
| Piperazines | 1 | 2019 | 109 | 0.680 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2018 | 56 | 0.650 |
Why?
|
| Pyridinium Compounds | 1 | 2017 | 21 | 0.630 |
Why?
|
| Cell Proliferation | 4 | 2021 | 1149 | 0.630 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 239 | 0.610 |
Why?
|
| MicroRNAs | 1 | 2021 | 386 | 0.570 |
Why?
|
| Indoles | 1 | 2017 | 154 | 0.570 |
Why?
|
| Cell Movement | 1 | 2017 | 545 | 0.490 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1426 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2018 | 31 | 0.320 |
Why?
|
| Neovascularization, Pathologic | 2 | 2018 | 122 | 0.300 |
Why?
|
| Mice | 7 | 2023 | 5668 | 0.290 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 82 | 0.220 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2021 | 8 | 0.210 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 2128 | 0.210 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 9 | 0.200 |
Why?
|
| Poly I-C | 1 | 2021 | 7 | 0.200 |
Why?
|
| Withanolides | 1 | 2021 | 8 | 0.200 |
Why?
|
| Animals | 7 | 2023 | 14307 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 242 | 0.190 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 6 | 0.190 |
Why?
|
| Mice, Nude | 2 | 2021 | 323 | 0.190 |
Why?
|
| Immunotherapy | 1 | 2021 | 91 | 0.190 |
Why?
|
| CDC2 Protein Kinase | 1 | 2019 | 17 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2019 | 54 | 0.180 |
Why?
|
| Biological Products | 1 | 2021 | 67 | 0.180 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 336 | 0.180 |
Why?
|
| Disease Progression | 1 | 2021 | 580 | 0.170 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 220 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 245 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 781 | 0.170 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 287 | 0.160 |
Why?
|
| Mucin-1 | 1 | 2018 | 8 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2020 | 226 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 43 | 0.160 |
Why?
|
| Humans | 8 | 2023 | 34853 | 0.150 |
Why?
|
| Male | 5 | 2023 | 18870 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2021 | 653 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2021 | 1802 | 0.140 |
Why?
|
| Apoptosis | 2 | 2021 | 1317 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 756 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2023 | 897 | 0.090 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2023 | 4 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2023 | 3 | 0.060 |
Why?
|
| Phosphates | 1 | 2023 | 49 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2023 | 42 | 0.060 |
Why?
|
| Adenosine | 1 | 2023 | 54 | 0.060 |
Why?
|
| Ubiquitination | 1 | 2023 | 54 | 0.060 |
Why?
|
| Lysosomes | 1 | 2023 | 80 | 0.060 |
Why?
|
| Female | 2 | 2021 | 19873 | 0.050 |
Why?
|
| Interferon Inducers | 1 | 2021 | 2 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 35 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 217 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 65 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 480 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2021 | 107 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 649 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2018 | 89 | 0.040 |
Why?
|
| Laminin | 1 | 2018 | 59 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2018 | 46 | 0.040 |
Why?
|
| Collagen | 1 | 2018 | 162 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 522 | 0.040 |
Why?
|